Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 149: 432-442, 2020 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-32004601

RESUMO

Dermatophytes belonging to Trichophyton ssp. are important anthropophilic and zoophilic pathogens, which developed resistance to griseofulvin, the common antifungal drug used to treat dermatophytosis. In this context, Moringa oleifera seed proteins have been described as antifungal agents with potential applications. Thus, this work aimed to evaluate the antidermatophytic in vitro, focusing on mechanisms, and in vivo potential of Mo-CBP4, purified from M. oleifera seeds. Mo-CBP4was purified after protein extraction with 50 mM Tris-HCl buffer, pH 8.0, and chromatography on chitin and CM Sepharose™ columns and antidermatophytic potential of Mo-CBP4 evaluated in vitro and in vivo. In vitro, Mo-CBP4 reduced in 50% the germination of microconidia of Trichophyton mentagrophytes at 45 µM; but did not show inhibition of mycelial growth. Mo-CBP4 (45 µM) presents the inhibitory activity even when incubated with N-acetyl-d-glucosamine (NAG). Analysis of the mechanisms of Mo-CBP4 revealed an increase in membrane permeability, ROS overproduction and damage to cell wall leading to microconidia death. Furthermore, using in vivo models, Mo-CBP4 (5, 10 and 20 mg g-1) reduced the severity and time of dermatophytosis. Altogether, these findings indicate that Mo-CBP4 has great potential for the development of novel antifungal drugs for the clinical treatment of dermatophytosis.


Assuntos
Hidrogéis/farmacologia , Moringa oleifera/química , Micoses/tratamento farmacológico , Proteínas de Plantas/química , Alérgenos/efeitos adversos , Alérgenos/química , Antifúngicos/química , Antifúngicos/farmacologia , Quitina/química , Humanos , Hidrogéis/química , Micoses/microbiologia , Micoses/patologia , Proteínas de Plantas/farmacologia , Sementes/química , Pele/efeitos dos fármacos , Pele/patologia , Esporos Fúngicos/efeitos dos fármacos , Esporos Fúngicos/patogenicidade , Tinha/tratamento farmacológico , Tinha/microbiologia , Tinha/patologia
2.
Biomed Res Int ; 2013: 578781, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23691507

RESUMO

Among the Bauhinia species, B. cheilantha stands out for its seed protein content. However, there is no record of its nutritional value, being used in a nonsustainable way in the folk medicine and for large-scale extraction of timber. The aim of this study was to investigate the food potential of B. cheilantha seeds with emphasis on its protein quality to provide support for flora conservation and use as raw material or as prototype for the development of bioproducts with high added socioeconomic value. B. cheilantha seeds show high protein content (35.9%), reasonable essential amino acids profile, low levels of antinutritional compounds, and nutritional parameters comparable to those of legumes widely used such as soybean and cowpea. The heat treatment of the seeds as well as the protein extraction process (to obtain the protein concentrate) increased the acceptance of diets by about 100% when compared to that of raw Bc diet. These wild legume seeds can be promising alternative source of food to overcome the malnutrition problem faced by low income people adding socioeconomic value to the species.


Assuntos
Bauhinia/química , Clima Desértico , Medicina Tradicional , Valor Nutritivo , Sementes/química , Testes de Toxicidade , Aminoácidos/análise , Animais , Lectinas/metabolismo , Masculino , Camundongos , Ratos , Ratos Wistar , Sementes/enzimologia , Tripsina/metabolismo , Urease/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...